Filter search criteria using below inputs
Click on magnifying glass icon to search
Company | Country | Symbol |
---|
Time | Volume | IMCR |
---|---|---|
09:32 ET | 264 | 50.97 |
09:38 ET | 100 | 51.36 |
09:39 ET | 390 | 51.35 |
09:43 ET | 475 | 50.77 |
09:45 ET | 1700 | 51.475 |
09:48 ET | 800 | 51.19 |
09:56 ET | 100 | 50.77 |
09:57 ET | 13854 | 50.65 |
09:59 ET | 300 | 50.92 |
10:01 ET | 2681 | 50.905 |
10:03 ET | 1126 | 50.4603 |
10:06 ET | 200 | 50.695 |
10:08 ET | 100 | 50.695 |
10:15 ET | 100 | 50.805 |
10:17 ET | 262 | 50.835 |
10:21 ET | 1000 | 50.71 |
10:24 ET | 300 | 50.705 |
10:33 ET | 405 | 50.94 |
10:35 ET | 3206 | 50.77 |
10:37 ET | 200 | 50.78 |
10:39 ET | 100 | 50.92 |
10:42 ET | 100 | 50.64 |
10:48 ET | 100 | 50.74 |
10:51 ET | 375 | 50.52 |
10:53 ET | 100 | 50.45 |
11:06 ET | 100 | 50.42 |
11:08 ET | 1000 | 50.3 |
11:09 ET | 200 | 50.18 |
11:11 ET | 275 | 50.291 |
11:13 ET | 200 | 50.29 |
11:22 ET | 300 | 50.39 |
11:38 ET | 100 | 50.37 |
11:47 ET | 400 | 50.29 |
11:49 ET | 11600 | 50.23 |
11:51 ET | 100 | 50.155 |
11:54 ET | 200 | 50.34 |
12:02 ET | 400 | 50.21 |
12:09 ET | 1216 | 49.985 |
12:16 ET | 100 | 50.11 |
12:18 ET | 240 | 49.98 |
12:21 ET | 100 | 49.89 |
12:23 ET | 400 | 49.83 |
12:25 ET | 100 | 49.74 |
12:27 ET | 1508 | 50.09 |
12:30 ET | 100 | 50.1 |
12:32 ET | 300 | 50.3 |
12:41 ET | 600 | 50.37 |
12:48 ET | 710 | 50.325 |
12:52 ET | 300 | 50.16 |
12:54 ET | 100 | 50.08 |
01:08 ET | 100 | 50.18 |
01:10 ET | 100 | 50.27 |
01:14 ET | 100 | 50.29 |
01:17 ET | 100 | 50.24 |
01:21 ET | 300 | 50.07 |
01:28 ET | 200 | 50.16 |
01:32 ET | 100 | 50.13 |
01:39 ET | 1300 | 50.135 |
01:48 ET | 153 | 50.1 |
01:53 ET | 923 | 50.105 |
01:55 ET | 603 | 50.1 |
02:00 ET | 300 | 50.01 |
02:04 ET | 248 | 50 |
02:06 ET | 100 | 50.09 |
02:13 ET | 100 | 50.035 |
02:18 ET | 300 | 50.1 |
02:20 ET | 900 | 50.1 |
02:22 ET | 800 | 50.24 |
02:26 ET | 200 | 50.34 |
02:27 ET | 200 | 50.49 |
02:29 ET | 600 | 50.35 |
02:31 ET | 300 | 50.44 |
02:33 ET | 100 | 50.44 |
02:36 ET | 1000 | 50.48 |
02:38 ET | 500 | 50.305 |
02:42 ET | 600 | 50.41 |
02:44 ET | 200 | 50.435 |
02:45 ET | 200 | 50.47 |
02:47 ET | 100 | 50.62 |
02:49 ET | 200 | 50.34 |
02:51 ET | 400 | 50.52 |
02:54 ET | 200 | 50.46 |
02:56 ET | 2998 | 50.36 |
02:58 ET | 400 | 50.37 |
03:02 ET | 970 | 50.48 |
03:03 ET | 200 | 50.54 |
03:05 ET | 100 | 50.62 |
03:07 ET | 39965 | 50.72 |
03:09 ET | 200 | 50.79 |
03:12 ET | 867 | 50.83 |
03:14 ET | 100 | 50.92 |
03:16 ET | 200 | 50.91 |
03:18 ET | 7900 | 50.915 |
03:20 ET | 300 | 51.09 |
03:21 ET | 200 | 51.09 |
03:23 ET | 500 | 51.02 |
03:25 ET | 2700 | 50.87 |
03:27 ET | 400 | 50.97 |
03:30 ET | 3560 | 50.755 |
03:34 ET | 500 | 50.785 |
03:36 ET | 400 | 50.86 |
03:38 ET | 400 | 50.72 |
03:39 ET | 700 | 50.68 |
03:41 ET | 100 | 50.7 |
03:43 ET | 688 | 50.59 |
03:45 ET | 793 | 50.82 |
03:48 ET | 400 | 50.8 |
03:50 ET | 1000 | 50.74 |
03:52 ET | 2640 | 50.82 |
03:54 ET | 1117 | 50.88 |
03:56 ET | 12100 | 50.78 |
03:57 ET | 3570 | 50.77 |
03:59 ET | 12425 | 50.67 |
Company sortable | Market Cap sortable | P/E Ratio (TTM) sortable | EPS Growth (5yr) sortable |
---|---|---|---|
Immunocore Holdings PLC | 2.5B | -40.2x | --- |
Blueprint Medicines Corp | 3.0B | -5.4x | --- |
Arrowhead Pharmaceuticals Inc | 2.8B | -15.4x | --- |
Denali Therapeutics Inc | 3.0B | -19.9x | --- |
Zai Lab Ltd | 2.5B | -6.2x | --- |
Cytokinetics Inc | 2.9B | -5.3x | --- |
Immunocore Holdings plc is a commercial-stage biotechnology company. The Company is engaged in the development of a class of T cell receptor (TCR), bispecific immunotherapies called immune mobilizing monoclonal TCRs Against X disease (ImmTAX), which is designed to treat a range of diseases, including cancer, infectious and autoimmune. It is developing a pipeline in multiple therapeutic areas, including five clinical stage programs in oncology and infectious disease, advanced pre-clinical programs in autoimmune disease and multiple earlier pre-clinical programs. Its lead product, KIMMTRAK, is a TCR therapeutic for the treatment of patients with unresectable or metastatic uveal melanoma (mUM), in the United States, European Union, Canada, Australia, and the United Kingdom. Its pipeline products include IMC-F106C, IMC-C103C, IMC-I109V, and IMC-M113V, among others. Its clinical programs are being conducted with patients with a range of cancers including melanoma, lung, gastric, and others.
Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.
Open a New Account, or Login if you're a client.
You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.
Open a New Account, or Login if you're a client.
Market Cap | $2.5B |
---|---|
Revenue (TTM) | $220.3M |
Shares Outstanding | 48.9M |
Dividend Yield | 0.00% |
Annual Dividend Rate | --- |
Ex-Dividend Date | 01-01-01 |
Pay Date | 01-01-01 |
Beta | --- |
EPS | $-1.26 |
Book Value | $7.03 |
P/E Ratio | -40.2x |
Price/Sales (TTM) | 11.3 |
Price/Cash Flow (TTM) | --- |
Operating Margin | -27.16% |
Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.
Open a New Account, or Login if you're a client.